Abstract
Despite current low rates, the incidence of arthroplasty-associated infections (AAI) is likely to increase over the next few years as the number of joint replacement operations continues to rise worldwide. AAI pose a challenge for both patients and surgeons. They have become a major economic burden on healthcare systems. Debridement and implant retention is not a widely considered option for chronic AAI probably due to low success rates. Negative Pressure Wound Therapy and intra-articular antibiotics instillation using VAC ULTA/VeraFlo system is an alternative strategy in the management of chronic AAI where implant retention is sought. Further evaluations and studies are needed to address the efficacy of this strategy and its cost effectiveness.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
